Associated Papers
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.
Takano M et al.
Pharmacogenomics and Personalized Medicine, 2017
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.
Etienne-Grimaldi MC et al.
Fundamental & Clinical Pharmacology, 2015
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.
Jo JC et al.
British Journal of Cancer, 2012
Select a paper to view details